Use of prothrombin complex concentrates for urgent reversal of dabigatran in the Emergency Department.

Management of bleeding in patients treated with direct oral anticoagulants. Crit Care (2016) 0.82

Use of 4-factor prothrombin complex concentrate in the treatment of a gastrointestinal hemorrhage complicated by dabigatran. Int J Emerg Med (2015) 0.80

Updates in the perioperative and emergency management of non-vitamin K antagonist oral anticoagulants. Crit Care (2015) 0.77

New oral pharmacotherapeutic agents for venous thromboprophylaxis after total hip arthroplasty. World J Orthop (2014) 0.75

A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey. Chest (2010) 10.29

Dabigatran versus warfarin in the treatment of acute venous thromboembolism. N Engl J Med (2009) 9.17

Reversal of rivaroxaban and dabigatran by prothrombin complex concentrate: a randomized, placebo-controlled, crossover study in healthy subjects. Circulation (2011) 6.47

Dabigatran etexilate--a novel, reversible, oral direct thrombin inhibitor: interpretation of coagulation assays and reversal of anticoagulant activity. Thromb Haemost (2010) 4.45

Reversal of dabigatran anticoagulation by prothrombin complex concentrate (Beriplex P/N) in a rabbit model. J Thromb Haemost (2012) 1.70

Prothrombin complex concentrates reduce blood loss in murine coagulopathy induced by warfarin, but not in that induced by dabigatran etexilate. J Thromb Haemost (2012) 1.07

Cost-effectiveness of dabigatran etexilate for the prevention of stroke and systemic embolism in UK patients with atrial fibrillation. Heart (2012) 1.05

Interpretation of point-of-care INR results in patients treated with dabigatran. Am J Med (2012) 1.04

Life-threatening bleeding in four patients with an unusual excessive response to dabigatran: implications for emergency surgery and resuscitation. Thromb Haemost (2012) 0.98

Switching from enoxaparin to dabigatran etexilate: pharmacokinetics, pharmacodynamics, and safety profile. Eur J Clin Pharmacol (2012) 0.88

Rivaroxaban versus enoxaparin for thromboprophylaxis after total hip or knee arthroplasty: a meta-analysis of randomized controlled trials. Eur J Clin Pharmacol (2010) 0.83

[Valproate-meropenem co-administration, an example of information shortcomings in relevant drug interactions]. Med Clin (Barc) (2009) 1.40

Tracheostomy tube in place at intensive care unit discharge is associated with increased ward mortality. Respir Care (2009) 1.11

Overuse of PPIs in patients at admission, during treatment, and at discharge in a tertiary Spanish hospital. Curr Clin Pharmacol (2010) 0.94

Drug-induced life-threatening potassium disturbances detected by a pharmacovigilance program from laboratory signals. Eur J Clin Pharmacol (2012) 0.90

Evaluation of the influence of sex and CYP2C19 and CYP2D6 polymorphisms in the disposition of citalopram. Eur J Pharmacol (2009) 0.85

Toward a clinical practice guide in pharmacogenomics testing for functional polymorphisms of drug-metabolizing enzymes. Gene/drug pairs and barriers perceived in Spain. Front Genet (2012) 0.82

Improving linezolid use decreases the incidence of resistance among Gram-positive microorganisms. Int J Antimicrob Agents (2012) 0.80

Acceptability and characteristics of 124 human bioequivalence studies with active substances classified according to the Biopharmaceutic Classification System. Br J Clin Pharmacol (2010) 0.80

Efficiency and effectiveness of the use of an acenocoumarol pharmacogenetic dosing algorithm versus usual care in patients with venous thromboembolic disease initiating oral anticoagulation: study protocol for a randomized controlled trial. Trials (2012) 0.79

Vancomycin-induced acute kidney injury detected by a prospective pharmacovigilance program from laboratory signals. Ther Drug Monit (2013) 0.78

[Results of a national survey on transfusion practice in Intensive Care Units]. Med Intensiva (2009) 0.75

[Iron deficiency anemia and use of intravenous iron in digestive disease]. Gastroenterol Hepatol (2010) 0.75

Acute complications and outcomes of acute head injury in adult patients with haemophilia. Eur J Emerg Med (2014) 0.75

Rifampin-related acute renal failure, thrombocytopenia, and leukocytoclastic vasculitis. Ann Pharmacother (2008) 0.75

Zika Virus Screening among Spanish Team Members After 2016 Rio de Janeiro, Brazil, Olympic Games. Emerg Infect Dis (2017) 0.75

Pharmacodynamic genetic variants related to antipsychotic adverse reactions in healthy volunteers. Pharmacogenomics (2013) 0.75